aztreonam has been researched along with cefotaxime in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (18.72) | 18.7374 |
| 1990's | 28 (13.79) | 18.2507 |
| 2000's | 87 (42.86) | 29.6817 |
| 2010's | 45 (22.17) | 24.3611 |
| 2020's | 5 (2.46) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cattoir, V; Nordmann, P; Poirel, L; Soares, A; Soussy, CJ | 1 |
| Chen, YG; Du, XX; Li, LJ; Shen, P; Wei, ZQ; Yu, YS | 1 |
| Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A | 1 |
| Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O | 1 |
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
| Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV | 1 |
| Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
| Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
| Bae, IK; Jeong, SH; Lee, SH; Lee, WG; Lee, YN | 1 |
| Chen, YT; Lauderdale, TL; Liao, TL; Shiau, YR; Shu, HY; Su, IJ; Tsai, SF; Wu, KM; Yan, JJ | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F | 1 |
| Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM | 1 |
| Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
| Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
| Bonnet, R; Neuwirth, C; Robin, F; Siebor, E | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 1 |
| Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
| Hsiao, YJ; Hu, RM; Huang, KJ; Wu, LT; Yang, TC | 1 |
| Amicosante, G; Celenza, G; De Santis, F; Forcella, C; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
| Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV | 1 |
| Gianneli, D; Loli, A; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Bonnet, R; Caniça, M; Manageiro, V; Mendonça, N | 1 |
| Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
| Adams-Haduch, JM; de Oliveira Garcia, D; Doi, Y; Freire, MP; Leite, D; Padoveze, MC; Paterson, DL; Silveira, FP; Szabo, D; Vaz, TM | 1 |
| Limansky, AS; Marchiaro, P; Mussi, MA; Pasteran, F; Tomatis, PE; Viale, AM; Vila, AJ | 1 |
| Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, TL; Cho, WL; Fung, CP; Shaio, MF; Wu, RC | 1 |
| Docquier, JD; Frère, JM; Rossolini, GM; Stoczko, M | 1 |
| Espedido, BA; Iredell, JR; Partridge, SR | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Bauernfeind, A; Keuleyan, E; Markovska, R; Queenan, AM; Rasshofer, R; Schneider, I | 1 |
| Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
| Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
| Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Galleni, M; Mammeri, H; Nordmann, P | 1 |
| Asensi, MD; Gales, AC; Monteiro, J; Peirano, G; Santos, AF | 1 |
| Goering, RV; Hanson, ND; Kurpiel, PM; Palepou, MF; Wolter, DJ; Woodford, N | 1 |
| Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J | 1 |
| Bradford, PA; Jones, CH; Petersen, PJ; Ruzin, A; Tuckman, M; Visalli, MA | 1 |
| Nordmann, P; Plésiat, P; Poirel, L; Rodriguez-Martinez, JM | 1 |
| Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS; Whichard, JM; Zioga, A | 1 |
| Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
| Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
| Nordmann, P; Poirel, L; Rodríguez-Martínez, JM | 1 |
| Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX | 1 |
| Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G | 1 |
| Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
| Adams-Haduch, JM; Bonomo, RA; Doi, Y; Endimiani, A; O'Keefe, A; Paterson, DL; Sidjabat, HE | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Brémont, S; Conroy, MC; Courvalin, P; Lambert, T; Moubareck, C | 1 |
| Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ | 1 |
| Giakkoupi, P; Miriagou, V; Papagiannitsis, CC; Pappa, O; Polemis, M; Tzouvelekis, LS; Vatopoulos, AC; Zioga, A | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Bauernfeind, A; Keuleyan, E; Markova, B; Markovska, R; Queenan, AM; Schneider, I | 1 |
| De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
| Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
| Higgins, PG; Lehmann, M; Nordmann, P; Poirel, L; Seifert, H | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 3 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
| Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
| Fortineau, N; Nordmann, P; Poirel, L; Rodriguez-Martinez, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
| Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Campos, J; Carrilero, L; Escudero, JA; Garcia-Cobos, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; San Millan, A | 1 |
| Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
| Bethel, C; Bonomo, RA; Choudhary, Y; Endimiani, A | 1 |
| De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM | 1 |
| Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
| Albuquerque, L; Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V | 1 |
| Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Al Naiemi, N; Debets-Ossenkopp, YJ; Nordmann, P; Poirel, L; Rodríguez-Martínez, JM | 1 |
| Galleni, M; Gutkind, G; Power, P; Rodríguez, MM; Sader, H | 1 |
| Bini, L; Bonomo, RA; Borgianni, L; Docquier, JD; Frère, JM; Matagne, A; Rossolini, GM; Vandenameele, J | 1 |
| Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E | 1 |
| Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S | 1 |
| Carattoli, A; García-Fernández, A; Giordano, A; Mancini, C; Miriagou, V; Papagiannitsis, CC; Venditti, M | 1 |
| Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Lagrutta, E; Nordmann, P; Pham, J; Poirel, L; Taylor, P | 1 |
| Bae, IK; Jeong, SH; Kim, J; Lee, K; Suh, B; Yong, D | 1 |
| Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
| Ishii, Y; Matsuzawa, H; Mura, K; Oishi, M; Sakai, H; Shimizu-Ibuka, A; Yamada, S | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Faulkner, KC; Hurley, KA; Weibel, DB | 1 |
| Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D | 1 |
| Hannecart-Pokorni, E; Nulens, E; Nyssen, HJ; Vanhoof, R | 1 |
| Bhutta, ZA; Farooqui, BJ; Naqvi, SH | 1 |
| Koenig, G; Simon, DM; Trenholme, GM | 1 |
| Alonso, T; Ariza, J; Esteve, M; Fernández Bañeres, F; Gudiol, F; Liñares, J; Xiol, X | 1 |
| Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M | 1 |
| Parry, MF | 1 |
| Edwardson, KF; Jones, J; Morris, DL; Pain, J; Slack, R; Strachan, C; Wilson, SR | 1 |
| Chimura, T; Hirayama, T; Matsuo, M; Morisaki, N | 1 |
| Agusti Vidal, A; Almela, M; de Celis, R; Deulofeu, R; Marco, F; Rabinad, E; Rodriguez-Roisin, R; Torres, A | 1 |
| Dionigi, R; Mozzillo, N; Ventriglia, L | 1 |
| Durgham, SM; Ishag, AH; Shibl, AM | 1 |
| Castilla, C; Ponte, C; Santamaría, M; Soriano, F | 1 |
| Lingaas, E; Midtvedt, T | 1 |
| Evagelopoulou, V; Giamarellou, H; Lelekis, M | 1 |
| Benson, CA; Trenholme, GM; Walton, FE | 1 |
| Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
| Donato, JB; Joseph, WS; LeFrock, JL; McCloskey, RV; Smith, BR; Weber, SJ | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Castilla, C; Fernández-Roblas, R; Ponte, C; Santamaría, M; Soriano, F | 1 |
| Perronne, C; Vildé, JL | 1 |
| Lewis, G; McDonald, PJ; Pruul, H | 1 |
| Van der Auwera, P; Verbist, L | 1 |
| Cocuzza, CE; Mattina, R; Raimondi, A | 1 |
| Canepari, P; Cornaglia, G; Pompei, R; Satta, G | 1 |
| Chin, NX; Neu, HC | 2 |
| Fournier, P; Labia, R; Morand, A; Philippin, JL; Pitton, JS | 1 |
| Androulakis, M; Giamarellou, H; Goumas, P; Petrikkos, G | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
| Bergeron, MG; Boucher, FD; Lavoie, GY | 1 |
| Amato, G; Anzivino, D; Bolletti-Censi, M; Covelli, I; Fortunato, A; Guarino, A; Gulletta, E; Lavitola, A; Nani, E; Spagnoletti, G | 1 |
| Inoue, M; Matsuda, K; Mitsuhashi, S; Nagashima, M; Nakagawa, S | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Borobio, V; Garcia-Iglesias, MC; Pascual, A; Perea, EJ | 1 |
| Dette, GA; Grobecker, H; Kees, F; Knothe, H; Naber, KG | 1 |
| Cooper, CE; Griffin, KE; Slocombe, B; White, AR | 1 |
| Edmondson, RA; Reading, C | 1 |
| Kohl, I; Then, RL | 1 |
| Huerre, M; Meyran, M; Thabaut, A | 1 |
| Ponte, MC; Soriano, F | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
| Gruninger, RP; Khan, MY; Nelson, SM; Obaid, SR | 1 |
| Aber, RC; Appelbaum, PC; Pankuch, GA; Tamim, J | 1 |
| LeBel, M; Lewis, GP; Paone, RP | 1 |
| Luzzaro, F; Pagani, L; Porta, F; Romero, E | 1 |
| Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
| Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F | 1 |
| Courvalin, P; Fonzé, E; Frère, JM; Goussard, S; Lamotte-Brasseur, J; Raquet, X | 1 |
| Gertner, J; Heym, B; Jarlier, V; Lacroix, O; Nicolas, MH; Péan, Y | 1 |
| Arlet, G; Fournier, B; Lagrange, PH; Philippon, A | 1 |
| Babálová, M; Krălíková, K; Krcméry, V; Kubonová, K | 1 |
| Domínguez Herrera, JM; Hernández Guisado, JM; Infante Cossio, P; Jiménez Mejías, ME | 1 |
| Han, P; Jacoby, GA | 1 |
| Bret, L; Chanal, C; Romaszko, JP; Sirot, D; Sirot, J | 1 |
| Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Lesická-Hupková, M; Mikovicová, A | 1 |
| Fernández-Roblas, R; Gadea, I; García-Corbeira, P; Ponte, C; Soriano, F | 1 |
| Chaibi, EB; Labia, R; Scanvic, AM; Scavizzi, MR; Soilleux, MJ | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Torsová, V | 1 |
| Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Krcméryová, T; Kubonová, K; Lesická-Hupková, M | 1 |
| Blahová, J; Hupková, M; Králiková, K; Krcméry, V; Kubonová, K; Lísková, A | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Bou, G; Cerveró, G; Martínez-Beltrán, J; Pérez-Díaz, JC | 1 |
| Baadran, I; Dajani, N; Mahafzah, A; Qadar, FA; Shehabi, AA | 1 |
| Arlet, G; Donay, L; Herrmann, J; Lagrange, PH; Nadjar, D; Philippon, A; Rouveau, M; Verdet, C | 1 |
| Domínguez, L; Garde, J; Herrero, IA; Moreno, MA; Porrero, MC; Teshager, T | 1 |
| Corkill, JE; Cuevas, LE; Greensill, J; Gurgel, RQ; Hart, CA | 1 |
| Chang, FY; Ho, M; Ishii, Y; Ma, L; Siu, LK; Yamaguchi, K | 1 |
| Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
| Gierczyński, R; Jagielski, M; Piekarska, K; Szych, J; Wardak, S; Wilk, E; Zacharczuk, K; Zawidzka, E | 1 |
| Escolano, Mde L; Febles-Casquero, A; García-Jalón, I; González, D; Leiva, J; Ojer-Usoz, E; Vitas, AI | 1 |
| Fang, ZL; Huang, X; Huang, YM; Qing, Y; Tian, GB; Zhang, XF | 1 |
| Chang, SC; Chen, PC; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
| Carlson, EE; Kocaoglu, O | 1 |
| Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C | 1 |
| Amini, E; Askari, P; Ghannadkafi, M; Namaei, MH; Salehabadi, A; Yousefi, M; Ziaee, M | 1 |
| Khan, AU; Maryam, L | 1 |
| Bhattacharjee, A; Chakravarty, A; Chanda, DD; Paul, D | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
| Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y | 1 |
| Adib, N; Afsharikhah, S; Bagheri, M; Ghanbarpour, R; Jajarmi, M; Mohseni, P | 1 |
1 review(s) available for aztreonam and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for aztreonam and cefotaxime
| Article | Year |
|---|---|
Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
Topics: Adult; Aged; Ascitic Fluid; Aztreonam; Bacterial Infections; Cefotaxime; Female; Gram-Negative Bacteria; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Prospective Studies; Superinfection | 1991 |
A comparison of aztreonam/metronidazole and cefotaxime/metronidazole in elective colorectal surgery: antimicrobial prophylaxis must include gram-positive cover.
Topics: Aztreonam; Bacterial Infections; Cefotaxime; Colon; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Metronidazole; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Rectum | 1990 |
Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Topics: Adult; Aged; Amikacin; Aztreonam; Cefotaxime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Random Allocation | 1989 |
Multicenter study of aztreonam in the prophylaxis of colorectal, gynecologic and urologic surgery.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Aztreonam; Cefotaxime; Colorectal Surgery; Female; Gentamicins; Humans; Hysterectomy; Italy; Male; Middle Aged; Multicenter Studies as Topic; Prostatectomy; Surgical Wound Infection | 1989 |
A comparative study of cefoxitin, cefotaxime, moxalactam and aztreonam kinetics in saliva.
Topics: Aztreonam; Cefotaxime; Cefoxitin; Humans; Moxalactam; Saliva | 1987 |
Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aztreonam; Cefotaxime; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Inulin; Iothalamic Acid; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Urinary Tract Infections | 1986 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
195 other study(ies) available for aztreonam and cefotaxime
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Enterobacter cloacae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Plasmids; Quinolones; Sequence Alignment | 2007 |
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Hospitals, University; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids | 2007 |
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids | 2007 |
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation | 2007 |
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2007 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Pneumonia, Bacterial; Sequence Analysis, DNA | 2007 |
Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechol 2,3-Dioxygenase; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Stenotrophomonas maltophilia | 2008 |
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Enterobacter aerogenes; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Sequence Analysis, DNA; Serratia marcescens; Structure-Activity Relationship; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States | 2008 |
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Edetic Acid; Greece; Humans; Imipenem; Integrons; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Kinetics; Klebsiella pneumoniae | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polymerase Chain Reaction | 2008 |
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Binding Sites; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Primers; DNA Transposable Elements; DNA, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Transformation, Genetic | 2008 |
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Molecular Sequence Data; Open Reading Frames; Pectobacterium carotovorum; Phenotype; Phylogeny; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
Topics: Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Bulgaria; Catalysis; Germany; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.
Topics: Asparagine; Bacterial Proteins; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Secondary; Serine | 2009 |
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil.
Topics: beta-Lactamases; Brazil; Carbapenems; Klebsiella pneumoniae | 2009 |
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Genetic Variation; Hydrolysis; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Genetic variability among ampC genes from acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain | 2009 |
Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155
Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Reproducibility of Results; Time Factors | 2009 |
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; beta-Lactamases; Burkholderia cepacia complex; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Hydrolysis; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Arginine; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Citrobacter freundii; Cysteine; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Glutamine; Humans; Hydrolysis; Inhibitory Concentration 50; Isoelectric Point; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Models, Molecular; Molecular Sequence Data; Plasmids; Salmonella enterica; Sequence Analysis, DNA; Species Specificity; Substrate Specificity; Transformation, Genetic | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporinase; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2009 |
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2009 |
First detection of plasmid-encoded blaOXY beta-lactamase.
Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Carbapenems; Integrons; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Plasmids | 2009 |
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary | 2009 |
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin | 2009 |
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Polymerase Chain Reaction | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bulgaria; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data | 2009 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Meropenem; Molecular Sequence Data; Oxacillin; Penicillins; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thienamycins | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Protein Conformation; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
Topics: Animals; beta-Lactamases; Cefaclor; Conjugation, Genetic; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Molecular Epidemiology; Molecular Sequence Data; Pasteurella multocida; Plasmids; Replicon; Spain; Species Specificity; Transformation, Genetic | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.
Topics: beta-Lactam Resistance; beta-Lactamases; Escherichia coli; Escherichia coli Proteins; Molecular Sequence Data | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Integrons; Middle Aged; Molecular Sequence Data; Netherlands; Pseudomonas Infections; Pseudomonas stutzeri; Sequence Homology, Amino Acid; Substrate Specificity | 2010 |
Novel chromosome-encoded CTX-M-78 beta-lactamase from a Kluyvera georgiana clinical isolate as a putative origin of CTX-M-25 subgroup.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Chromosomes, Bacterial; Gentamicins; Humans; Kluyvera; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Sulfamethoxazole; Trimethoprim | 2010 |
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; DNA Mutational Analysis; Enzyme Stability; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Protein Conformation; Protein Folding; Structure-Activity Relationship | 2010 |
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed | 2010 |
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2010 |
An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Imipenem; Klebsiella pneumoniae; Meropenem; Molecular Sequence Data; Porins; Thienamycins | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2010 |
Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Reverse Transcriptase Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult | 2010 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Binding Sites; Cefotaxime; Escherichia coli; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Sequence Homology, Amino Acid; Structure-Activity Relationship; Substrate Specificity | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
5-Alkyloxytryptamines are membrane-targeting, broad-spectrum antibiotics.
Topics: Acinetobacter baumannii; Alkylation; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; HEK293 Cells; Humans; Salmonella typhimurium; Staphylococcus aureus; Tryptamines | 2016 |
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline | 2019 |
Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Microbial Sensitivity Tests; Species Specificity | 1992 |
Therapy of multidrug resistant typhoid in 58 children.
Topics: Adolescent; Ampicillin Resistance; Aztreonam; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Ofloxacin; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Humans; Imipenem; Leukemia, Monocytic, Acute; Leukocytes, Mononuclear; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Spheroplasts | 1990 |
Aztreonam susceptibility testing. A retrospective analysis.
Topics: Ampicillin; Aztreonam; Bacteria; Cefotaxime; Ceftazidime; Gentamicins; Mezlocillin; Microbial Sensitivity Tests | 1990 |
[Clinical effects of cefodizime against infectious diseases in obstetrics and gynecology].
Topics: Adolescent; Adult; Aged; Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Clindamycin; Drug Evaluation; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged | 1989 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
Topics: Animals; Aztreonam; Bacteroides fragilis; Bacteroides Infections; Cefotaxime; Escherichia coli Infections; Female; Gentamicins; Microbial Sensitivity Tests; Peritonitis; Rats; Rats, Inbred Strains | 1989 |
The influence of cefoperazone, cefotaxime, ceftazidime and aztreonam on phagocytosis by human neutrophils in vitro.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Cefoperazone; Cefotaxime; Ceftazidime; Escherichia coli; Humans; In Vitro Techniques; Neutrophils; Phagocytosis; Proteins | 1989 |
Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
Topics: Amikacin; Aztreonam; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1989 |
Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans | 1986 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Topics: Anti-Bacterial Agents; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa | 1986 |
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins | 1987 |
In vivo significance of the inoculum effect of antibiotics on Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Cefmetazole; Cefotaxime; Cefoxitin; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains | 1988 |
[Third generation cephalosporins, monobactams and carbapenems].
Topics: Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Imipenem; Thienamycins | 1988 |
Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
Topics: Aztreonam; Cefotaxime; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Neutrophils; Phagocytosis | 1988 |
Belgian multicenter study on the in vitro activity of aztreonam against gram-negative bacilli.
Topics: Aztreonam; Cefotaxime; Ceftazidime; Cross Reactions; Drug Resistance, Microbial; Enterobacteriaceae | 1988 |
Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Ceftazidime; Ceftriaxone; Cephamycins; Drug Stability; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1988 |
Evaluation of bactericidal activity of cefotaxime and other beta-lactams by a novel method.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cefsulodin; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Kinetics; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Time Factors | 1988 |
In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.
Topics: Aztreonam; Bacteria; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Microbial Sensitivity Tests; Monobactams; Structure-Activity Relationship | 1987 |
[Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Cefoxitin; Cephamycins; Imipenem; Klebsiella; Klebsiella pneumoniae; Plasmids; Thienamycins | 1987 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefixime; Cefotaxime; Enoxacin; Haemophilus influenzae; Leucomycins; Microbial Sensitivity Tests; Naphthyridines | 1987 |
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Topics: Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftazidime; Cephalosporins; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1986 |
[Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
Topics: Aztreonam; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Structure-Activity Relationship | 1986 |
In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
Topics: Aztreonam; Bacteria; beta-Lactamases; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Drug Stability; Kinetics; Monobactams | 1986 |
The in-vitro activity and beta-lactamase stability of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Culture Media; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1986 |
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin | 1986 |
Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Leucomycins; Microbial Sensitivity Tests | 1987 |
Temocillin. In vitro antibacterial activity.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cefuroxime; Dose-Response Relationship, Drug; Drug Interactions; Enterobacteriaceae; In Vitro Techniques; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1985 |
Beta-lactamase stability of temocillin.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefotetan; Cephamycins; Chromosomes, Bacterial; In Vitro Techniques; Penicillins; Plasmids | 1985 |
Affinity of carumonam for penicillin-binding proteins.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Binding, Competitive; Carboxypeptidases; Carrier Proteins; Cefotaxime; Ceftriaxone; Electrophoresis, Polyacrylamide Gel; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
[Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Topics: Acinetobacter; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1985 |
Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteroides; Cefotaxime; Escherichia coli; Kinetics; Microbial Sensitivity Tests | 1984 |
In-vitro activity of SQ 26,776 against multiply-resistant enterobacteria--preliminary results.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Lactams; Moxalactam | 1981 |
Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1983 |
Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Topics: Acinetobacter; Alcaligenes; Anti-Bacterial Agents; Aztreonam; Bordetella; Cefamandole; Cefotaxime; Cefoxitin; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Aerobic Bacteria; Moraxella; Pseudomonas | 1983 |
Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
Topics: Anti-Bacterial Agents; Autoanalysis; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Creatinine; Humans; Male | 1983 |
Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Humans; Isoelectric Focusing; Monobactams; Plasmids; Serratia marcescens | 1995 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
Topics: Aztreonam; beta-Lactamases; Binding Sites; Catalysis; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Escherichia coli; Hydrolysis; Kinetics; Mutation; Penicillins; Plasmids; Stereoisomerism; Substrate Specificity | 1994 |
Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillin Resistance; Phenotype; Pseudomonas aeruginosa; Ticarcillin | 1994 |
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase.
Topics: Amino Acid Sequence; Aztreonam; Base Sequence; beta-Lactamases; Cefotaxime; Chromosomes, Bacterial; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Molecular Sequence Data; Mutation; Promoter Regions, Genetic | 1994 |
[Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Topics: Acinetobacter; Aztreonam; Cefotaxime; Ceftazidime; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter; Hospitals, University; Humans; Monobactams; R Factors | 1996 |
[Acute bacterial parotitis caused by Serratia marcescens].
Topics: Acute Disease; Aztreonam; Cefotaxime; Cephalosporins; Child; Diagnosis, Differential; Female; Humans; Middle Aged; Monobactams; Parotitis; Serratia Infections; Serratia marcescens; Time Factors; Tomography, X-Ray Computed | 1996 |
Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Microbial; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 1996 |
Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceae.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Enterobacteriaceae; Enzyme Inhibitors; Hospitals, Teaching | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.
Topics: Aztreonam; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Conjugation, Genetic; Drug Resistance, Microbial; Enterobacter cloacae; Mutation; Operon; Selection, Genetic | 1996 |
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal; Escherichia coli Infections; Male; Mice; Peritoneal Diseases; Piperacillin | 1996 |
TEM-8: a paradoxical ceftazidimase that owes its uniqueness to the presence of serine residues at positions 164 and 238.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli; Penicillin G | 1997 |
Transferable resistance to cefotaxime, ceftazidime, and aztreonam and production of extended-spectrum beta-lactamase in a strain of Salmonella enteritidis.
Topics: Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Multiple; Humans; Infant; Monobactams; Plasmids; Salmonella enteritidis; Transformation, Bacterial | 1997 |
Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalothin; Czech Republic; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Ofloxacin | 1997 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
Further occurrence of extended-spectrum beta-lactamase-producing Salmonella enteritidis.
Topics: Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Drug Resistance, Microbial; Humans; Hydrolysis; Monobactams; Salmonella enteritidis; Salmonella Infections | 1998 |
Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple; Escherichia coli; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Proteus mirabilis | 1998 |
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactams; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Monobactams | 1998 |
Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cloning, Molecular; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Microbial Sensitivity Tests; Monobactams; Sequence Analysis, DNA; Substrate Specificity | 1999 |
High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units.
Topics: Aztreonam; beta-Lactam Resistance; Cefotaxime; Ceftazidime; Ceftriaxone; Cross Infection; Gram-Negative Bacteria; Humans; Incidence; Intensive Care Units; Jordan; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Prospective Studies; Sensitivity and Specificity | 2000 |
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Hafnia; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Plasmids; Polymerase Chain Reaction | 2000 |
Surveillance of antimicrobial resistance in Escherichia coli strains isolated from pigs at Spanish slaughterhouses.
Topics: Abattoirs; Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Data Collection; Drug Resistance, Microbial; Escherichia coli; Feces; Humans; Imipenem; Microbial Sensitivity Tests; Spain; Sulfonamides; Swine; Tetracycline; Trimethoprim | 2000 |
SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Brazil; Cefotaxime; Ceftazidime; DNA Mutational Analysis; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Polymorphism, Restriction Fragment Length | 2001 |
CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.
Topics: Amino Acid Substitution; Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Monobactams; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; Taiwan | 2002 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
[Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland].
Topics: Adult; Aged; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Poland; Species Specificity | 2010 |
Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, Spain.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cattle; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Food Contamination; Food Microbiology; Meat Products; Microbial Sensitivity Tests; Poultry; Prevalence; Spain; Swine | 2013 |
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutant Chimeric Proteins; Plasmids; Urinary Tract Infections | 2014 |
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus Infections; Proteus mirabilis; Taiwan; Urinary Tract Infections; Young Adult | 2014 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Escherichia coli strain DC2.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefotaxime; Cefuroxime; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins | 2015 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prospective Studies; Young Adult | 2016 |
First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Ciprofloxacin; Clone Cells; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression; Gentamicins; Humans; Iran; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Prevalence; Virulence Factors | 2017 |
Combination of aztreonam and cefotaxime against CTX-M-15 type β-lactamases: A mechanism based effective therapeutic approach.
Topics: Aztreonam; Bacterial Proteins; beta-Lactamases; Catalysis; Cefotaxime; Enterobacteriaceae | 2018 |
An insight into analysis and elimination of plasmids encoding metallo-β-lactamases in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cross Infection; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Dodecyl Sulfate; Suppuration; Urine | 2020 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Iran; Phylogeny; Prevalence; Urinary Tract Infections | 2023 |